Eric J. Topol

TL;DR: A multifaceted strategy aimed at prevention of vein graft disease is emerging, elements of which include: continued improvements in surgical technique; more effective antiplatelet drugs; increasingly intensive risk factor modification; and a number of evolving therapies, such as gene transfer and nitric oxide donor administration, which target vein graft Disease at an early and fundamental level.

TL;DR: The usefulness of base-line levels of cardiac troponin T and CK-MB and the electrocardiographic category assigned at admission and the presence of confounding factors that impair the detection of ischemia were assessed to assess the usefulness of outcome.

TL;DR: Most common SNPs have now been assessed in genome-wide studies for statistical associations with many complex traits, including many important common diseases, and only a limited amount of the heritable component of any complex trait has been identified.

TL;DR: Myeloperoxidase levels, in contrast to troponin T, creatine kinase MB isoform, and C-reactive protein levels, identified patients at risk for cardiac events in the absence of myocardial necrosis, highlighting its potential usefulness for risk stratification among patients who present with chest pain.

TL;DR: Administration of amlodipine to patients with CAD and normal blood pressure resulted in reduced adverse cardiovascular events and evidence of slowing of atherosclerosis progression.